Neurology & Movement Disorders
Advanced Clinical Research for Movement Disorders
Movement disorders can significantly impact mobility, coordination, and quality of life. CenExel partners with sponsors to advance innovative therapies for neurological conditions through specialized research, experienced investigators, and patient-focused clinical trial programs.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Leading Movement Disorder Clinical Research
CenExel provides specialized expertise in movement disorder clinical trials, supporting sponsors with scientifically rigorous and operationally efficient research solutions. Our experienced neurology teams focus on improving patient outcomes through advanced treatments for conditions affecting movement, balance, and motor control.
Conditions Covered
Movement Disorder Conditions We Research
Our movement disorder research programs support a broad range of neurological and motor-related conditions across adult and aging populations.
- Parkinson’s Disease
- Essential Tremor
- Huntington’s Disease
- Dystonia
- Tourette Syndrome
- Multiple System Atrophy (MSA)
- Progressive Supranuclear Palsy (PSP)
- Lewy Body Dementia
Our Approach
Why Sponsors Choose CenExel for Movement Disorder Research
CenExel combines scientific expertise, operational excellence, and patient-centered recruitment strategies to support successful movement disorder clinical trials from Phase I through Phase IV.
01
Expert Neurology Teams
Our investigators specialize in neurological and movement disorder research with extensive experience in complex CNS studies.
02
Advanced Biomarker Strategy
We support movement disorder trials with imaging, biomarker analysis, and data-driven patient assessments.
03
Diverse Patient Access
Our nationwide site network provides access to diverse patient populations across multiple neurological indications.
04
Faster Enrollment
CenExel’s recruitment strategies and site coordination help reduce enrollment timelines and improve retention.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase movement disorder clinical research — from first-in-human studies to large-scale post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our experienced CNS and neurology research teams provide comprehensive support for movement disorder studies, including patient recruitment, clinical operations, regulatory management, and data quality oversight.
Movement Disorders Task Force
CenExel supports sponsors developing innovative treatments for neurological and movement-related disorders through experienced investigators, advanced site capabilities, and diverse patient access.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
